Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Tablets: SOP for Corrective and Preventive Action (CAPA) Implementation – V 2.0

Posted on By

Tablets: SOP for Corrective and Preventive Action (CAPA) Implementation – V 2.0

Standard Operating Procedure for Corrective and Preventive Action (CAPA) Implementation

Department Tablet
SOP No. SOP/TAB/217/2025
Supersedes SOP/TAB/217/2022
Page No. Page 1 of 5
Issue Date 01/03/2026
Effective Date 06/03/2026
Review Date 01/03/2027

1. Purpose

The purpose of this SOP is to outline the procedure for identifying, investigating, and implementing Corrective and Preventive Actions (CAPA) to address deviations, non-conformances, or any issues within the tablet manufacturing process. The goal is to prevent recurrence and improve the overall quality management system.

2. Scope

This SOP applies to all tablet manufacturing processes where deviations, non-conformances, or potential quality issues arise. It includes the identification, investigation, analysis, and resolution of the problem through corrective and preventive actions.

3. Responsibilities

  • Quality Assurance (QA) Manager: Responsible for overseeing the CAPA process, ensuring proper implementation, and verifying the effectiveness of corrective actions and preventive measures.
  • Production Manager: Responsible for providing information on production deviations and assisting in the implementation of corrective actions.
  • Quality Control (QC) Team: Responsible for investigating non-conformances related to testing and providing feedback for CAPA implementation.
  • Regulatory Affairs Team: Ensures that corrective actions comply with regulatory requirements and are implemented accordingly.

4. Accountability

The QA

Manager is accountable for ensuring that CAPA procedures are followed. The Production and QC teams are responsible for providing information regarding any deviations or non-conformances and implementing corrective actions. The regulatory team ensures all corrective and preventive actions meet the necessary regulatory standards.

See also  Tablets: SOP for QA Involvement in Tablet Packaging Line Validation - V 2.0

5. Procedure

5.1 Identification of Non-Conformances

  1. Identify non-conformances through routine audits, inspection reports, customer complaints, or quality control testing.
  2. Document all non-conformances, including a description of the issue, affected batch or product, and initial observations (Annexure-1).
  3. Assess the severity of the non-conformance to determine whether immediate corrective action is required to prevent further impact on product quality.

5.2 Investigation of Root Cause

  1. Investigate the root cause of the non-conformance. This may involve reviewing batch records, conducting interviews, and analyzing production processes and equipment (Annexure-2).
  2. Use tools like Root Cause Analysis (RCA), Fishbone Diagram, or Failure Mode Effect Analysis (FMEA) to identify underlying causes (Annexure-3).
  3. Determine if the issue is isolated or if it could affect future batches or processes.

5.3 Corrective Action (CA) Implementation

  1. Develop corrective actions to address the root cause of the non-conformance. Corrective actions may include process changes, equipment maintenance, training, or changes to standard operating procedures (SOPs) (Annexure-4).
  2. Implement the corrective action immediately or within a defined timeframe. Document the implementation process and results (Annexure-5).
  3. Verify that the corrective action has effectively resolved the non-conformance and prevent recurrence.

5.4 Preventive Action (PA) Implementation

  1. Develop preventive actions to eliminate the risk of recurrence of the issue in the future. This may include modifying procedures, adding additional controls, or performing routine maintenance on equipment (Annexure-6).
  2. Implement preventive actions as part of the continuous improvement process.
  3. Verify the effectiveness of preventive actions by conducting periodic reviews and inspections to ensure no recurrence of the non-conformance.
See also  Tablets: SOP for Tablet Compression Force Monitoring and Adjustments - V 2.0

5.5 Verification and Effectiveness Check

  1. Once corrective and preventive actions are implemented, conduct effectiveness checks by reviewing batch records, inspecting affected processes, or conducting re-testing.
  2. Ensure that corrective actions have resolved the issue and that preventive measures are actively reducing the risk of recurrence (Annexure-7).
  3. If the corrective actions or preventive measures are ineffective, revisit the investigation and take further corrective actions.

5.6 Documentation and Record Keeping

  1. Ensure that all CAPA records, including investigations, corrective actions, preventive actions, and effectiveness checks, are documented and securely stored (Annexure-8).
  2. Retain CAPA records for a minimum of 5 years or as required by applicable regulations.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • CAPA: Corrective and Preventive Action
  • RCA: Root Cause Analysis

7. Documents

  1. Non-Conformance Report (Annexure-1)
  2. Root Cause Analysis Report (Annexure-2)
  3. Corrective Action Plan (Annexure-4)
  4. Implementation Report (Annexure-5)
  5. Preventive Action Plan (Annexure-6)
  6. Effectiveness Check Results (Annexure-7)
  7. CAPA Documentation Records (Annexure-8)

8. References

  • 21 CFR Part 211 – Current Good Manufacturing Practice for Finished Pharmaceuticals (US FDA)
  • ISO 9001 – Quality Management Systems
  • GMP Guidelines for Pharmaceutical Manufacturing
See also  Tablets: SOP for Cleaning Verification of Coating Pans Between Batches - V 2.0

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Non-Conformance Report

Non-Conformance ID Description Batch Number Raised By Corrective Action Required
NC001 Potency out of specification Batch123 John Doe Recalibrate equipment and retest

Annexure-2: Root Cause Analysis Report

Root Cause ID Cause Description Corrective Action
RCA001 Incorrect calibration of tablet hardness tester Recalibrate and implement routine calibration checks

Annexure-3: Corrective Action Plan

Action ID Action Description Completion Date
CAP001 Recalibrate tablet hardness tester 06/03/2026

Annexure-4: Implementation Report

Action ID Implemented By Result
CAP001 Jane Smith Successful recalibration

Annexure-5: Preventive Action Plan

Action ID Action Description Completion Date
PA001 Implement daily calibration checks for tablet hardness tester 07/03/2026

Annexure-6: Effectiveness Check Results

Action ID Test Conducted Result Action Verified By
PA001 Tablet hardness testing Passed QA Manager

Annexure-7: CAPA Documentation Records

Document Type Location Retention Period
Corrective Action Plan Document Archive 5 years

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP creation New process QA Head
01/02/2025 2.0 Added more detailed documentation requirements Annual review QA Head
Tablet Manufacturing V2.0 Tags:GMP tablet manufacturing SOP, SOP for tablet production, SOP for tablet quality control, SOP tablet inspection process, SOP tablet packing and sealing, Tablet batch record review, Tablet blending SOP, Tablet cleaning and maintenance, Tablet coating procedure, Tablet compression SOP, Tablet disintegration test procedure, Tablet dissolution procedure, Tablet formulation SOP, Tablet friability testing SOP, Tablet labeling and packaging SOP, Tablet manufacturing equipment SOP, Tablet manufacturing SOP, Tablet manufacturing SOPs, Tablet packaging SOP, Tablet production procedure, Tablet quality assurance SOP, Tablet quality control SOP, Tablet sampling and in-process testing SOP, Tablet stability testing SOP, Tablet storage and handling procedure, Tablet uniformity testing procedure, Tablet weight variation SOP

Post navigation

Previous Post: API Manufacturing: SOP for Labeling of Raw Materials with Status Tags – V 2.0
Next Post: Aerosol: SOP for Stability Testing of Actuators and Valves – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version